Business Information
The group's principal activities are to manufacture and sell prescription, over-the-counter generic drugs and nutritional products. These drugs are in liquid and semi-solid dosage forms including higher margin prescription products. The company sells its products in two primary markets: generic pharmaceuticals and branded products. The company markets its generic pharmaceuticals primarily under the hi-tech name. The company also markets a line of branded products primarily for people with diabetes, including diabetic tussin (R), diabetiderm (R), diabetisweet (R), diabetitrim(R) and multi-betic (r). The group markets more than 100 products to over 100 customers. The customers comprise of chain drug stores, drug wholesalers, managed care purchasing organizations, certain federal government agencies, generic distributors, mass merchandisers, and mail-order pharmacies. The brand names include h-t and rx choice.
|
|
Name |
Title
|
Email
|
| Bernard Seltzer | Chmn. | N/A | | William Peters | CFO, VP | N/A | | Arthur Goldberg | VP - Finance | N/A | | Christopher Losardo | VP - Corporate Development | N/A | | Edwin Berrios | VP - Sales, Marketing | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 78,020 | 11,453 | | 2005 | 67,683 | 8,288 | | 2004 | 56,366 | 6,592
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
